newsfilter
← Latest News
PR Newswire·

NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe...